Walgreens 90-Day At Retail yields savings for PBM
Walgreen Co. reported that clients of pharmacy benefit manager Navitus Health Solutions have saved $3.3 million in seven months through the Walgreens 90-Day At Retail prescription drug program.
CDR
Cardinal acquires pharmaceutical distributor in China
Cardinal Health Inc. has wrapped up a $470 million deal to acquire Zuellig Pharma China, a leading health care distribution business in China, known locally as Yong Yu, and the nation’s largest pharmaceutical importer.
Crest Oral-B unveils Clinical Pro-Health System for Gingivitis
Procter & Gamble Co.’s Crest Oral-B brand duo is introducing the Clinical Pro-Health System for Gingivitis, a product set that according to the company is clinically tested to virtually eliminate gingivitis.
Perrigo rolls out generics for Aleve, Xyzal
Perrigo has launched Naproxen Sodium Soft Gels and, via its licensor and supplier Synthon, levocetirizine allergy tablets. The company said Monday that the Naproxen Sodium Soft Gels are the generic equivalent of Bayer HealthCare’s Aleve Liquid Gels (220 mg), an over-the-counter analgesic.
NRF: Encouraging start for holiday retail sales
Shoppers turned out in greater numbers and had a higher average spend this Black Friday weekend versus a year ago, according to the National Retail Federation (NRF).
Kroger, Safeway take part in UnitedHealth Part D program
The Kroger Co. and Safeway Inc. are participating in a UnitedHealthcare Medicare Part D program designed to lower members’ out-of-pocket costs for prescription drugs.
Study warns of big changes in Medicare Part D plans
Medicare patients need to be aware of significant formulary changes when choosing a prescription drug plan for next year, according an Avalere Health study of 2011 Medicare Part D plans.
Cardinal names new exec to head Medicine Shoppe
John Fiacco has been appointed vice president of Medicine Shoppe and Medicap Pharmacies and will take over leadership of both drug store franchises from Terry Burnside, who has stepped down, according to Cardinal Health Inc.
Energizer wraps up American Safety Razor acquisition
Energizer Holdings Inc. has closed its acquisition of American Safety Razor Co. Energizer said late Tuesday that under the transaction it is acquiring substantially all of the assets of American Safety Razor for $301 million in cash and the assumption of certain liabilities.
GSK to sell U.S. penicillin facility, products to Dr. Reddy’s
GlaxoSmithKline PLC has agreed to the sale of its United States oral penicillin facility and product portfolio to Dr. Reddy’s Laboratories. Dr. Reddy’s said Tuesday that under the agreement, GSK will transfer ownership of its penicillin manufacturing site in Bristol, Tenn.
Generic versions of Accolate ship
Par Pharmaceutical Companies Inc. and Dr. Reddy’s Laboratories have released generic versions of AstraZeneca’s Accolate asthma drug in the United States. Par said Monday that it has entered into an exclusive U.S.
New line from Aveeno takes aim at eczema
Johnson & Johnson’s Aveeno brand has introduced the Aveeno Eczema Therapy collection for infants and adults and partnered with the National Eczema Association to educate people with the skin condition.
NACDS: Accountable care groups should include pharmacists
Pharmacy can play a key role in accountable care organizations (ACOs), which seek to improve health care quality and control costs for patients, according to the National Association of Chain Drug Stores.
Diabetes patients struggle to pay for supplies, poll finds
More than 50% of people with diabetes are finding it a struggle to afford diabetic supplies, according to a survey by diabetes community network dLife. DLife said Tuesday that with the U.S.
London Drugs serves up photo gift software
London Drugs is offering software that enables customers to create photo books on their home computers.
Coalition calls for repeal of ‘cough and cold tax’
A broad coalition of industry groups representing retail pharmacies and makers of over-the-counter drugs is urging Congress to nullify a new health care reform requirement that would prevent consumers from using flexible spending accounts (FSAs) to buy nonprescription medicines.